Chemotherapy failure due to cellular drug resistance is still a major problem in most cancer patients. A variety of drug resistance mechanisms have been characterised using in vitro cell lines made resistant to the different classes of anti-cancer agents. Qualitative and quantitative alterations in cellular target proteins, drug metabolism, repair mechanisms and drug efflux from the cell, among others, can cause drug resistance in vitro. However, a clear relationship between these cellular biochemical alterations and chemotherapy failure in patients could not be estabhshed for most drug resistance mechanisms identified so far. These resistance mechanisms have in common that they concern, directly or indirectly, the interaction of the drug molecule with its intracellular target molecules. A different approach for the elucidation of the mechanisms of cellular drug resistance is to study how cells are killed by cytotoxic drugs and to unravel the events that occur as a consequence of the drug-target interaction that finally leads to cell death.
It is now well appreciated that most anti-cancer drugs can exert their cytotoxic action by triggering a conserved, geneactivated programme for cell death, often referred to as apoptosis (Wyllie et al., 1980; Dive and Hickman, 1991; Eastman and Barry, 1992; Sen and D'Incalci, 1992; Wyllie, 1993) . Apoptosis is the normal physiological method of cell death during, for example, embryogenesis and tissue homeostasis, and can also be induced by a large variety of external stimuli, such as viral infections and toxic insults. Therefore, it may well be that the susceptibility of a cancer cell to druginduced apoptosis is an important determinant in the therapeutic response (Dive and Hickman, 1991) . Recent evidence strongly suggests that modulation of the apoptotic cell response can lead to drug resistance. It has been shown that the bcl-2 gene can prevent or markedly reduce cell kill induced by anti-cancer drugs (Reed, 1994) . This oncogene is a member of a superfamily of related genes, including bax (Oltvai et al., 1993) and bcl-x (Boise et al., 1993) , which normally regulate apoptosis in mammalian cells and are thought to induce cytotoxic drug resistance by blocking a final common pathway to apoptotic cell death. Although the molecular mechanism of apoptosis is yet unknown, several other (onco)genes have been shown to mediate or modulate the apoptotic pathway, among which are the tumoursuppressor gene p53 and the proto-oncogene c-myc. In some cell systems, overexpression of these genes induces or facilitates apoptosis (Yonish-Rouach et al., 1991; Evan et al., 1992; Shaw et al., 1992) . It is very likely that other (onco)genes involved in cell proliferation will also play a role in the process of apoptosis. Since oncogenic activation of the ras gene is frequently observed in human cancer (Bos, 1989) , we investigated, in our effort to characterise drug resistance parameters in human tumours, the effects of the c-H-ras oncogene on chemotherapy-induced apoptosis.
Materials and nethod

Cell lines
The rhabdomyosarcoma cell line R2 and the transfectants, R2T24 and R2NEO, have been described previously (Hermens and Bentvelzen, 1992), and were maintained in monolayer culture in Dulbecco's modified culture medium, supplemented with 10% fetal calf serum, 100 units m.1 penicillin, 100 jgmlm' streptomycin and 2mM L-glutamine. The cells were cultured at 37'C in a humidified incubator with 8.5% carbon dioxide. The R2T24 cell line was cotransfected with the plasmid pT24 carrying the c-H-ras oncogene (Reddy et al., 1982) and the plasmid pKo carrying the neo gene (Davies and Gimenez, 1980) . The R2NEO cell line was transfected with the neo gene only. Southern blot analysis with the 6.6 kb BamHI fragment of the pT24 plasmid revealed that the R2T24 cell line contains six copies of the c-H-ras oncogene per cell (Hermens and Bentvelzen, 1992) . The R2T24 cells exhibit constitutive expression of the c-H-ras oncogene, as determined by dot-blot and Northern blot assay (Hermens and Bentvelzen, 1992 (Wyllie et al., 1980) . The landmark of apoptosis is endonucleolysis, a process whereby nuclear DNA is initially degraded at the nucleosomal linker regions (Arends et al., 1990 (au.) by calculating the mean fluorescence distribution of each cell sample. Cells (2 x 10i ml-') in RPMI without phenol red buffered with 10 mM HEPES buffer (pH 7.4) were incubated at 3TC and 8.5% carbon dioxide either for 60 min with doxorubicin (1 gM) or for 60 min with doxorubicin (1 pM), followed by another incubation for 60 min after the addition of cyclosporin A (3 FuM). The incubations were stopped by putting the cells on melting ice. After washing twice with ice-cold PBS (pH 7.4) the cells were stored at 4C until flow cytometric analysis.
Relts
Growth characteristics of the cell lines Rat rhabdomyosarcoma R2 cells were stably transfected with plasmids containing the ras oncogene and/or the neo gene, resulting in the establishment of the cell lines R2T24 and R2NEO respectively. These cell lines have been described previously (Hermens and Bentvelzen, 1992) , and their relevant growth characteistics will be sumarised here. The R2T24 cell line contains six copies of the ras oncogene per cell, as estimated by Southern blot analysis. Dot-blot and Northen blot hybridisation showed abundant ras mRNA expression in R2T24 cells. The in vitro doubling time of the R2, R2T24 and R2NEO cell lines is 0.9, 1.0, and 1.0 days respectively. Cell cycle analysis of cells in logarithmic growth showed no differences between the R2, R2T24 and R2NEO cells in the distribution over the cell cycle phases. The mean proportions of cells in GI, S and G2/M were 50%, 31% and 19% for R2 cells, 54%, 30% and 16% for R2T24 cells and 56%, 28% and 16% for R2NEO cells.
Doxorubicin-induced apoptosis
A 2 h incubation of exponentially growing R2 or R2NEO cells with doxorubicin (1 FuM) resulted in an apoptotic response, as determined 24 h later by cell morphology, DNA degradation and in situ nick translation assay. The cells had a typical apoptotic feature with condensed chromatin and nuclear fragmentation. DNA degradation in nucleosomesized fragments could be detected by qualitative gel electrophoresis (Sdlins and Cohen, 1987) (data not shown). Prior to drug incubation, the R2 parental and the R2NEO cell lines only showed very low levels of spontaneous apoptosis, as determined by in situ nick translation assay (Figure la) . However, after doxorubicin incubation apoptotic cells could be distinguished in R2 and R2NEO cultures on the basis of DNA content and biotin-dUTP labelling In Figure lb -Id, R2NEO cell cultures are shown at t = 24, t = 48 and t = 72 h after doxorubicin exposure. Extensive biotin-dUTP labelling was observed at t = 24 h (Figure lb) , which increased with time. At t =48 h, two distinct apoptotic cell populations were present, representing about 70% of the total number of cells analysed. One cluster of apoptotic cells is only shifted on the vertical axis owing to incorporation of biotin-dUTP and has a normal DNA content. The other cluster of apoptotic cells has a reduced DNA content, probably as a result of loss of diffusible DNA of low molcular weight (200-1000 bp; mono-and short oligonuceosomes) (Gorczyca et al., 1993a) . At t = 72 h, the vast majority (about 90%) of cells were apoptotic, and formed one cluster with predominantly a subnormal DNA content (Figure ld) (Figure 3 ). lines (R'. R'N-EO and R'T2'4 the addition ot cyclosponin A lfinal concentration S lM to the incubation medium led to an increase in intracellular doxorubicin accumulation. probablv as a result of inhibition of endogenous rat rmdr Pal-coprotein molecules Deuchars eo al.. 1992h. which in rodent cell lines often haxve a Somexv-hat elevated basal expression level. How-ever. also in the presence of cyclosporin A. no differences xwere found in intracellular doxorubicin accumulation betxveen the control cell lines (R' and R'N-EO) and the ra>-transfected cell line R2'T'44. Apparently. in the R2 cells constitutix-e expression of the c-H-raS oncoLene does not enhance mdr P-Olxcoprotein expre.ssion. Thus. the differences in drug-induced apoptosis and cell survival between the control cell line, and the R'T'4 cell, cannot be ascribed to differences in intracellular drug accumulation.
Discussion n
In the present study xwe showxed that cells xwith constituti-e expression of the c-H-raS oncogene wAere approximately S-to f-fold more resistant to doxorubicin wAhen companng the drug concentrations needed for identical log cell kill in the d raS-transfected cells. and in control cells In accordance wAith these drug resistance data. drug-induced apoptosi-.. as estimated bx the in XIiuu nick translation as..ax. xvas delaved and ienificantl1 loxwer in the c-H-ra'-transtected cells than in the control cellS. This inhibition of drug-induced apoptosis bx constitutix-e c-H-ra' oncogene expression xvas not absolute but relati-e. since 4 daxvs after a ' h drug exposure wxith 1 piN doxorubicin exen about 60°o of the c-H-raS-transfected cell. xvere trigaered into apoptosi-. Hox-ever. in the control neotransfected culture. about 100°o ot the cells xvere apoptotic at that time. In the clonogenic assax. no colonies were scored in the R'N-EO cultures at 1 imI doxorubicin. while only a S log cell k-ill wAas found in the R'T'4 cultures at that drug concentration. Apparently. con.stitutive expression of the c-H-raS oncogene promotes cell survival after cytotoxic drug expo- (Lowe et al., 1993) , and from two studies it can be concluded that bcl-2 interferes in the apoptotic signal transduction pathway 'downstream' of the events associated with the interactions of the drug molecules with the intracellular target molecules (Fisher et al., 1993; Kamesaki et al., 1993) . One study particularly worth mentioning here linked bcl-2 with a member of the ras superfamily (Fernandez-Sarabia and Bischoff, 1994) . In human cell extracts, the bcl-2 protein has been found to be associated with the ras-related protein R-ras p23 (FernandezSarabia and Bischoff, 1994) . The authors hypothesised that, if R-ras were a component of a signal transduction pathway mediating the induction of apoptosis, the association of Rras p23 with bcl-2 could thus lead to suppression of apoptosis. However, in the same study, no association was found between bcl-2 and other members of the ras superfamily, making a similar scenario for the H-ras oncogene less likely.
The c-ras p21 proteins participate in the control of cell proliferation as signal transducers from cell-surface receptors to the nucleus. The serine/threonine kinase raf-1 probably acts as an effector of ras function (Kolch et al., 1991; Leevers et al., 1994; Stokoe et al., 1994) , and cells triggered into apoptosis by growth factor deprivation can be protected by activated raf (Troppmair et al., 1992) . Therefore, an interesting possibility that deserves further study is that the antiapoptotic effect of the c-H-ras oncogene is mediated by activated raf-l.
Mutational activation of ras proto-oncogenes is frequently observed in human tumours (Bos, 1989) , and the inhibitory effect of constitutive ras oncogene expression on druginduced apoptosis in vitro could have implications for tumour cell response to cytotoxic drug treatment in cancer patients. Our in vitro data showed that in doxorubicin at 1 JiM, a concentration within the clinical range of plasma concentrations, the neo-transfected cultures did not survive, whereas a significant proportion of the ras-transfected cells survived indeed and finally repopulated the cultures. If this phenomenon also takes place in tumours expressing endogenous ras oncogenes, these tumours might be less susceptible to anti-cancer drug treatment, and it could be anticipated that such drug-resistant tumour cells contribute to the recurrence of tumours. Cell, 74, [609] [610] [611] [612] [613] [614] [615] [616] [617] [618] [619] 
